Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS
· Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Dec 27, 2024, 3:19 PM EST
Ampio Pharmaceuticals Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
568.00
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.66B |
| Ryman Healthcare Limited | 458.44M |
| Verano Holdings Corp. | 897.57M |
| Vireo Growth Inc. | 98.53M |
| Medexus Pharmaceuticals Inc. | 104.76M |
Ampio Pharmaceuticals News
- 9 months ago - Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation - PRNewsWire
- 9 months ago - Ampio Announces Voluntary Delisting and SEC Deregistration - PRNewsWire
- 11 months ago - Ampio Provides Update on Results from Pre-IND Enabling Studies - PRNewsWire
- 1 year ago - Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal Actions - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals to Present at the Emerging Growth Conference - PRNewsWire
- 1 year ago - Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201 - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals Announces Reverse Stock Split - PRNewsWire
- 1 year ago - Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common Stock - PRNewsWire